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Garcinia Linn. plants having rich natural xanthones and benzophenones with anti-inflammatory activity attracted a great deal
of attention to discover and develop them as potential drug candidates. Through screening targeting nitric oxide accumulation
in stimulated macrophage, we found that 1,3,5,7-tetrahydroxy-8-isoprenylxanthone (TIE) had potential anti-inflammatory effect.
To understand how TIE elicits its anti-inflammatory activity, we uncovered that it significantly inhibits the production of nitric
oxide (NO) and prostaglandin E2 (PGE2) in LPS/IFN𝛾-stimulated RAW264.7 cells. In further study, we showed that TIE reduced
the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), two key molecules responsible for the
production of NO and PGE2 during inflammation progress. Additionally, TIE also suppressed the expression of inflammatory
cytokines IL-6, IL-12, and TNF-𝛼. TIE-led suppression in iNOS, COX-2, and cytokines production were probably the consequence
of TIE’s capability to block ERK and p38MAPK signaling pathway. Moreover, TIE blocked activation of nuclear factor-kappa B
(NF-𝜅B) as well as NF-𝜅B regulation of miR155 expression. Our study suggests that TIE may represent as a potential therapeutic
agent for the treatment of inflammatory diseases.
1. Introduction
Acute inflammatory response represents an initial protective
mechanism in the body. However, excessive and chronic
inflammation results in severe damage of cells and tissues.
Emerging evidences support the hypothesis that chronic
inflammation plays a critical role in various pathological
conditions, including atherosclerosis, autoimmune disorders,
neurodegenerative diseases, and inflammation related vari-
ous human cancers [1].
Nitric oxide (NO) is a free radical that is synthesized
from L-arginine by nitric oxide synthase (NOS). There are
three types of NOS: two constitutive NOS, eNOS and nNOS,
and one inducible NOS (iNOS). Constitutive NOS generate
nanomolar concentration of NO and are known to mediate
various physiological functions. Contrarily, iNOS produces
NO at the level ofmicromolar concentration that often results
in pathological consequences such as chronic inflammation
[2]. PGE2 are synthesized from arachidonic acid by cyclooxy-
genase (COX) during the inflammatory reaction. Two COX
isoenzymes are known as COX-1 and COX-2. COX-1 is
expressed constitutively in most cells and involved in home-
ostasis, whereas COX-2 is not produced in normal tissues
until being induced by chemical and physical stimulations
and enhanced by oncogenes, growth factors, and cytokines
[3].
LPS triggers a series of signal transduction events which
lead to the activation of NF-𝜅B, mitogen-activated protein
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kinase (MAPK) signaling pathway, and differential expres-
sion ofmiRNAs that contribute to the inflammatory response
[4].
NF-𝜅B is an essential transcription factor that regulates
proinflammatory gene expression such as iNOS, COX-2, and
interleukin-6 (IL-6) [5]. In mammals, three major MAPKs
subfamilies have been described such as ERK, JNK, and p38
MAPK. Secretion of several macrophage factors such as IL-6
andNO requiresMAPK activity [6]. miR155 represents a typ-
ical multifunctional miRNA and contributed to the progres-
sive inflammatory diseases that expression in macrophages
was correlated positively with proinflammatory cytokine
expression [7, 8].
There are some cross talks between these classical inflam-
matory pathways.MAPKs can be activated by Toll-like recep-
tor 4 (TLR4) leading to the activation of nuclear translocation
of NF-𝜅B and finally initiate proinflammatory responses [9].
NF-𝜅B is activated by phosphorylation of I𝜅B𝛼 via activation
of MAPKs and then migrates into the nucleus and activates
the expression of inflammatory cytokines andmediators [10].
miR155 induction requires NF-𝜅B signaling to upregulate
fos/jun transcription factors during the responses to infection
[11].
Garcinia esculenta Y. H. Li (Clusiaceae) is one ofGarcinia
Linn. species, the fruit of which is edible and juicy with
sweet and sour taste; meanwhile it is a well-known Chi-
nese traditional medicine with multiple pharmacological
functions in treating inflammation and tumor, distributed
in the western and northwestern part of Yunnan province
in China [12]. However, mechanisms associated with its
anti-inflammatory effect are not clear. During the previous
course of bioassay-guided screening compounds from twig of
Garcinia esculenta Y. H. Li, we found 1,3,5,7-tetrahydroxy-
8-isoprenylxanthone (TIE) suppressed NO accumulation in
stimulated macrophage [13]. In the present paper, we further
study its mechanism on LPS/IFN𝛾-induced inflammatory
responses in murine macrophages RAW264.7 cells.
2. Materials and Methods
2.1. Materials and Reagents. TIE (molecular weight 328Da)
was isolated from twig of Garcinia esculenta Y. H. Li (Clu-
siaceae), and the collection, identification, and specimen
restoration were described in the previous report [13]. The
chemical structure of TIE is shown in Figure 1. The purity of
TIE was detected by HPLC and the results suggested a purity
of above 98%.
Murine recombinant IFN𝛾 and NF-𝜅B p50/p65 EZ-TFA
transcription factor assay kit were purchased from Millipore
(Bedford, MA, USA); mouse PGE2 and IL-6 ELISA kit were
purchased from Cayman Chemical Company (Ann Arbor,
MI, USA); lipopolysaccharide (LPS; Escherichia coliO111:B4),
dimethyl sulfonamide (DMSO), N-(1-naphthyl)-enthylend-
iaminedihydrochloride, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoleum (MTT), and L-N6-(1-iminoethyl)lysine
hydrochloride (L-NIL, iNOS selective inhibitor) were
obtained from Sigma Chemical Co. (St. Louis, MO,
USA); RPMI-1640 was purchased from Gibco Invitrogen
Corporation (Grand Island, NY, USA); fetal bovine serum
CH3H3C
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O
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Figure 1: Chemical structure of TIE.
(FBS) was purchased from Hyclone (Logan, UT, USA);
TRIzol Reagent, lipofectamine TM 2000, Reverse Tran-
scription Kit, and SYBR Green PCR Master Mix regents
were obtained from Invitrogen (Carlsbad, CA, USA). The
promoter-luciferase plasmid for NF-𝜅B was kindly provided
by Professor Jin-wen Xu; Dual Luciferase Reporter reagents
were purchased from Promega (Madison, WI, USA).
Antibodies used in this study include the following: iNOS
monoclonal antibody from Abcam (Cambridge, MA, USA);
p-p38, T-p38, p-JNK, T-JNK, p-ERK1/2, and T-ERK1/2 and
𝛽-actin antibodies from Cell Signaling Technology (Beverly,
MA, USA); TaqMan MicroRNA Reverse Transcription Kit
and TaqMan Universal Master Mix purchased from Applied
Biosystems (Waltham, MA, USA); ECL regent kit purchased
from GE Healthcare Life Sciences (Buckinghamshire, UK).
2.2. Cell Culture. RAW264.7 cells were originally obtained
from the American Tissue Culture Collection. Cells were
maintained in RPMI 1640 medium supplemented with 10%
FBS at 37∘C in a humidified 5% CO
2
atmosphere.
2.3. Assay for Cell Viability. Cell viability was assessed by
MTT assay. RAW264.7 cells were cultured in a 96-well plate
(5000 cells/well) in an incubator at 37∘C, 5% CO
2
, and 95%
humidity. TIE was dissolved in DMSO and added after dilu-
tion with culture media to 3.125, 6.25, 12.5, and 25𝜇M at final
concentration of DMSO never exceeding 0.1%.The cells were
incubated with 10𝜇L MTT (5mg/mL in phosphate-buffered
saline, pH = 7.4) for 4 h at 37∘C and discarded the supernatant
followed by adding 150 𝜇L DMSO. Absorbance was mea-
sured at 490 nm in a microplate reader (Molecular Devices,
Sunnyvale, CA). The absorbance of control (untreated) cells
was considered as 100% of viability.
2.4. Measurement of NO Production. RAW264.7 cells were
plated in a 96-well plate (1× 105 cells/well) overnight, followed
by the addition of 10U/mL IFN𝛾 and 100 ng/mL LPS for
24 h in the presence or absence of different dosage of TIE
with increasing concentration at 3.125, 6.25, 12.5, and 25𝜇M,
and L-NIL (50 𝜇M), a selected iNOS inhibitor. To analyze
NO production, 100𝜇L of supernatant was incubated with
equal volume of Griess solution (1% sulfanilamide in 5%
phosphoric acid and 1% 𝛼-naphthylamine in distilled water)
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Table 1: Primer sets for qRT-PCR.
Gene name Forward primer Reverse primer
iNOS GGAGCGAGTTGTGGATTGTC GTGAGGGCTTGGCTGAGTGAG
COX-2 TGCCTGGTCTGATGATGTATG AGTAGTCGCACACTCTGTTGT
IL-6 CCACTTCACAAGTCGGAGGCTTA GTGCATCATCGCTGTTCATACAATC
IL-12p35 ACCTGCTGAAGACCACAGATGACA TAGCCAGGCAACTCTCGTTCTTGT
IL-12p40 ACCTGTGACACGCCTGAAGAAGAT TCTTGTGGAGCAGCAGATGTGAGT
TNF-𝛼 ATGGGAAGGGAATGAATCCACC GTCCACATCCTGTAGGGCGTCT
TBK1 ACTGGTGATCTCTATGCTGTCA TTCTGGAAGTCCATACGCATTG
𝛽-actin GCTACAGCTTCACCACCACAG GGTCTTTACGGATGTCAACGTC
at room temperature for 10min and absorbance was then
read at 540 nm. Since NO content was reflected by the
amount of nitrite, a calibration curve was generated using
sodium nitrite. The amount of nitrite in the supernatants
was calculated based on the calibration curve.The percentage
inhibition of NO production is evaluated using the formula
{1-[(nitrite amount of fraction-treated)/(nitrite amount of
vehicle)]}× 100.
2.5. Detection of PGE2 and IL-6 in Supernatant. Inhibitory
effects of TIE on the PGE2 and cytokine IL-6 production
from LPS plus IFN𝛾 treated RAW264.7 cells were detected
by sandwich ELISA KIT according to the manufacturer’s
instruction. After incubationwith different dosage of TIE and
stimulation with LPS plus IFN𝛾 on RAW264.7 cells for 24 h,
supernatants were harvested and assayed for PGE2 and IL-
6. Results of three independent experiments were used for
statistical analysis. L-NIL (50 𝜇M) was used as the positive
control.
2.6. RNA Isolation and Quantitative qRT-PCR. Total RNA
was extracted using TRIzol Reagent according to manu-
facturer’s instruction. The concentration and integrity of
purified RNA were measured by absorption of light at
260 and 280 nm (A260/280). From each sample, 2.0 𝜇g of
total RNA was then reverse transcribed to single-stranded
cDNA by Invitrogen Reverse Transcription Reagents. Then
qPCR analyses were performed on the aliquots of the cDNA
preparations with SYBR Green PCR Master Mix to detect
quantitatively the gene expression of iNOS, COX-2, IL-6, IL-
12p35, IL-12p40, TNF-𝛼, TBK1, and 𝛽-actin (an internal stan-
dard) using Applied Biosystems 7500HTFast Real-Time PCR
System (Applied Biosystems Inc., Foster City, CA, USA).The
2
−ΔΔCT method was utilized to analyze the fold increase. The
primers used (Sangon, shanghai, China) are listed in Table 1.
2.7. TaqManMicroRNA Real-Time RT-PCR Assays. The reac-
tions were set according to the manufacturer’s protocol.
Briefly, total RNA was purified by TRIzol. For each reaction,
10 ng of total RNA was used for reverse transcription using
TaqMan MicroRNA Reverse Transcription Kit and reverse
transcription primers for mmu-miR155 and the housekeep-
ing gene RNU6B. Real-time PCR quantification was per-
formed using TaqMan PCR primers and TaqMan Universal
Master Mix using the following conditions: 16∘C for 30min,
42∘C for 30min, and 85∘C for 5min on Applied Biosystems
7500HT Fast Real-Time PCR System. The samples were
measured in triplicate cases. RNU6B endogenous control was
used for normalization, and expression levels were presented
as 2−ΔΔCT with standard deviation.
2.8. Transient Transfection and Dual Luciferase Reporter
Assay. For the reporter assay, briefly, cells were seeded into
24-well plates at a density of 5 × 105 cells/well in 500𝜇L
of DMEM without antibiotics and incubated overnight. The
cells in each well were transiently transfected with NF-𝜅B
luciferase reporter construct and internal control Renilla
luciferase vector using lipofectamine TM 2000 reagent
according to the manufacturer’s procedures. Five hours after
transfection, the cells were washed with phosphate-buffered
saline and then supplied with fresh medium with FBS and
treated with TIE (3.125, 6.25, 12.5, and 25 𝜇M) and L-NIL
(50 𝜇M) as the positive control for 1 h before stimulation with
LPS and IFN𝛾 for 18 h. Subsequently, luciferase activities were
measured in cell lysates placed in opaque 96-well plates using
Dual Luciferase Reporter reagents following manufacturer’s
instruction. Luciferase activity was normalized to transfec-
tion efficiency as monitored by Renilla luciferase expression.
The level of luciferase activity was determined compared to
control cells with no stimulation.
2.9. The DNA-Binding Activity of NF-𝜅B Assay. The DNA-
binding activity of NF-𝜅B in nuclear extracts was measured
using the NF-𝜅B p50/p65 EZ-TFA transcription factor assay
kit according to the manufacturer’s instructions. Briefly, the
cells were pretreated with different-concentrations of TIE
and stimulated for 30min with LPS plus IFN𝛾. The nuclear
protein extracts of each sample were added to each well
after measuring its concentration. The plates were incubated
for 1 h at room temperature. After washing each well with
wash buffer, 100 𝜇L of diluted NF-𝜅B antibody was added
to each well, and then the plates were incubated further for
1 h. After washing wells with wash buffer, 100 𝜇L of diluted
HRP-conjugated antibody was added to each well, followed
by 1 h incubation. 100 𝜇L of developing solution was added
to each well for 5min, followed by the addition of stop
solution. Finally, the absorbance of each sample at 450 nm
was determined with a spectrophotometer within 5min, and
the final p50/p65 binding activity of each treatment groupwas
normalization by protein concentration.
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Figure 2: Effect of TIE onNO and PGE2 production in LPS/IFN𝛾-stimulated RAW264.7 macrophages. (a) RAW264.7 cells were treated with
TIE (3.125–25 𝜇M) or 50 𝜇ML-NIL for 24 h. Cell viability was measured byMTT assay. Changes in survival are represented as percentages of
the control group. (b) Cells were plated at a density of 1 × 105 cells/well in a 96-well plate and allowed to attach overnight. Cells were treated
with the various concentrations of TIE (3.125–25𝜇M) or 50 𝜇ML-NIL and incubated with LPS (100 ng/mL) and IFN𝛾 (10U/mL) in fresh FBS-
free medium for 24 h. The nitrite production was measured by the Griess reaction. (c) Cells were treated with the indicated concentrations
of TIE (12.5, 25 𝜇M) and incubated with LPS (100 ng/mL) and IFN𝛾 (10U/mL) in fresh FBS-free medium for 24 h. The PGE2 concentration
in cell supernatant was determined by ELISA kit. The values were presented as mean ± SEM of three independent experiments. ##𝑃 < 0.01;
#
𝑃 < 0.05 versus control group; ∗∗𝑃 < 0.01; ∗𝑃 < 0.05 versus model group.
2.10. Protein Extraction and Western Blotting Analysis. Pro-
tein samples (25–50𝜇g/mL) were mixed with loading buffer,
boiled for 5min, and then separated through 7.5% or 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Proteins were transferred to nylon membranes
by electrophoretic transfer. The membranes were blocked in
10%nonfat drymilk (1 h), rinsed, and incubatedwith primary
antibodies in TBST overnight at 4∘C. Primary antibody was
removed, membranes were washed three times in TBST, and
peroxidase-labeled secondary antibody was added for 1 h at
room temperature. Following three washes in TBST, bands
were visualized by ECL regent kit and exposure to X-ray film.
2.11. Statistical Analysis. The results are presented as means ±
standard error of the mean (SEM). Student’s test was used to
analyze the difference between treated and untreated groups.
Statistically significant differences between multiple groups
were calculated by the application of an analysis of variance
(ANOVA) test. 𝑃 < 0.05 was considered statistically signifi-
cant.
3. Results
3.1. Concentration-Dependent Inhibition of TIE on LPS/IFN𝛾-
Induced NO and PGE2 Production with Nontoxic Effects. To
determine the effects of TIE on cell viability, RAW264.7 cells
were initially seeded in 96-well plates followed by different
treatments. Results of the MTT assay after 24 h treatment
indicated that none of the treatments with TIE at the different
concentrations from 3.125 to 25𝜇Mwas toxic as compared to
the untreated cells, as well as positive control L-NIL at 50𝜇M
(𝑃 > 0.05) (Figure 2(a)).
Since TIE has been shown to exhibit inhibition of NO
production in our previous screening, increasing concen-
tration of TIE (3.125, 6.25, 12.5, and 25 𝜇M) was tested on
RAW264.7 cells with and without stimulation. The result
shows that 24 h inflammatory factors treatment triggered 30-
fold increase of nitrite concentration, a biomarker of NO pro-
duction. Application of TIE dose-dependently attenuatedNO
production while treatments with TIE without LPS stimula-
tion had a mild inhibitory effect on NO production (data not
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Figure 3: Effect of TIE on iNOS and COX-2 expression in LPS/IFN𝛾-stimulated RAW264.7 cells. (a, b) RAW264.7 cells were plated at a
density of 1 × 106 cells in 30mm dish overnight and treated with varying concentrations of TIE with treatment of LPS (100 ng/mL) and IFN𝛾
(10U/mL) for 4 h. Total RNA was isolated and subjected to qRT-PCR. 𝛽-actin mRNA was used as an internal control for standardization.
(c) RAW264.7 cells were plated at a density of 1 × 106 cells in 30mm dish overnight. TIE was added with the treatment of IFN𝛾 (10U/mL)
plus LPS (100 ng/mL) for 6 h. Whole cell lysates were prepared and subjected to Western blotting. 𝛽-actin protein was used as an internal
control for standardization.The data shown are representative of three independent experiments. ##𝑃 < 0.01, #𝑃 < 0.05 versus control group;
∗∗
𝑃 < 0.01, ∗𝑃 < 0.05 versus model group.
shown), with a maximum effect of 62.51%NO reduction with
25 𝜇MTIE (Figure 2(b)). TIE also reduced PGE2 production
in a concentration-dependent manner after treatment of 24 h
(Figure 2(c)).
These results suggest that TIE selectively inhibits NO
and PGE2 production. These results also indicate that the
inhibitory effect of TIE on NO and PGE2 production in LPS/
IFN𝛾-stimulated cells is not caused by cellular toxicity.
3.2. TIE Treatment Prevents LPS/IFN𝛾-Induced iNOS and
COX-2 Expression at mRNA and Protein Level. Since TIE
can effectively reduce LPS/IFN𝛾-induced NO production,
the fact that iNOS is responsible for LPS/IFN𝛾-induced NO
production indicates that TIE might block NO production
by decreasing the amount of iNOS. We hypothesized that
TIE might also possess potent inhibition of iNOS expression,
since iNOS always regulated by NF-𝜅B at transcription level
[14]. We tested this possibility by determining the effect of
TIE on iNOS mRNA and protein in LPS/IFN𝛾-stimulated
RAW264.7 cells with the aid of quantitative RT-PCR (qRT-
PCR) and Western blot analysis. Results showed that
LPS/IFN𝛾 stimulation elevated the mRNA and protein level
of iNOS, and TIE pretreatment diminished LPS/IFN𝛾-
induced iNOS gene and protein expression in RAW264.7
cells. TIE was found to decrease the levels of COX-2 mRNA
and protein too (Figure 3).
These results suggested that TIE might significantly sup-
press LPS-induced PGE2 via inhibiting COX-2 expression at
the transcriptional level.
3.3. Secretion and Expression of Inflammatory Cytokines Are
Suppressed by TIE. The effects of TIE on the secretion and
expression of proinflammatory cytokines including IL-6, IL-
12, and TNF-𝛼 were investigated by ELISA kit and qRT-PCR,
respectively.
TNF-𝛼 and IL-6 are potent proinflammatory cytokines
induced during inflammation progress, accompanied with
interleukin-12 (IL-12) playing the essential role in immune
defense against infection [15, 16].
Under stimulation of LPS plus IFN𝛾 for 4 h, the mRNA
levels from proinflammatory genes IL-6, IL-12p35, and p40
were highly induced andTNF-𝛼 enhanced its expression after
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Figure 4: Effect of TIE on proinflammatory cytokines in LPS/IFN𝛾-stimulated RAW264.7 cells. (a, b, c) RAW264.7 cells (1 × 106 cells/dish)
were treated with varying doses of TIE with IFN𝛾 (10U/mL) plus LPS (100 ng/mL) for 4 h. Total RNAwas isolated and subjected to qRT-PCR
to determine the level of IL-6 and IL-12p35/p40 mRNA. (d, e) RAW264.7 cells were treated with IFN𝛾 (10U/mL) plus LPS (100 ng/mL) in
the presence of varying concentrations of TIE for 24 h. Total RNA was isolated and subjected to qRT-PCR to determine the level of TNF-𝛼
mRNA. Conditionedmedia were collected and subjected to ELISA to determine the amount of IL-6.The values (means± SEM)were obtained
from three independent experiments. ##𝑃 < 0.01, #𝑃 < 0.05 versus control group; ∗∗𝑃 < 0.01, ∗𝑃 < 0.05 versus model group.
24H stimulation. Treatment of cells with TIE significantly
decreased the expression of IL-6, IL-12p35/p40, and TNF-𝛼
(Figures 4(a), 4(b), 4(c), and 4(d)).
LPS/IFN𝛾 stimulation increased not only IL-6 expression,
but also the secretion of IL-6. Coincubation of TIE and
proinflammation stimulation for 24 h showed the strong sup-
pression of this proinflammatory cytokine in cell supernatant
(Figure 4(e)).
These data showed that TIE maybe interfere in the
transcription level and protein secretion progress of IL-6.
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Inflammatory cytokines IL-12p35/p40 and TNF-𝛼 also can be
reduced by TIE.
3.4. TIE Inhibits Induced NF-𝜅B Luciferase Activity via Sup-
pression Nuclear Translocation of the p65 and p50 Subunits.
NF-𝜅B plays a pivotal role in regulation of the expression
of iNOS, COX-2, and inflammatory cytokines such as IL-6
and IL-12 [5]. To investigate the underlyingmechanism of the
inhibition of TIE on iNOS and COX-2 expression in stimu-
lated cells, luciferase reporter assay was used to explore the
effects of TIE on NF-𝜅B-dependent reporter gene expression
following proinflammatory treatment. RAW264.7 cells were
transiently cotransfected with a pNF-𝜅B reporter vector.
Cells were incubated with TIE (3.125, 6.25, 12.5, and
25 𝜇M) and LPS plus IFN𝛾 for 18 h.
The results indicated that LPS/IFN𝛾 treatment for 18 h
induced NF-𝜅B reporter activity almost 9-fold, and TIE
reduced the expression of NF-𝜅B luciferase in a concentra-
tion-dependentmanner (Figure 5(a)), with amaximumeffect
of a 63.50% reduction when the cells were treated with 25𝜇M
TIE, which was similar to the results of the positive control
L-NIL at the concentration of 50𝜇M.
Because p65 and p50 are the major subunits of the NF-
𝜅B heterodimer, the translocation of p65 and p50 subunits
from the cytoplasm to the nucleus after being released from
I𝜅B𝛼waswell investigated. As shown in Figures 5(b) and 5(c),
the concentrations of p65 and p50 subunits were increased in
the nucleus after LPS/IFN𝛾 treatment; pretreatment with TIE
reversed these trends.
TBK1 belongs to I𝜅B kinase (IKK) family that can active
IRF3/IRF7 and NF-𝜅B pathway to regulate inflammatory
responses in macrophages [17, 18]. So we also detected the
expression of TBK1; the result showed TBK1 was influenced
by TIE (Figure 5(d)).
Taken together, these findings confirmed that TIE sup-
pressed the expression of iNOS, COX-2, and cytokines at least
in part via NF-𝜅B-dependent mechanism.
3.5.MAPK Signaling Pathways Are the Target of TIE-Mediated
Inhibition. LPS induction of cytokine expression occurs via
activation ofMAPK and key protein phosphorylation follow-
ing binding to TLR4 [4]. MAPKs play an important role in
the transcriptional regulation of LPS-induced expression of
iNOS and COX-2 via activation of the transcription factor
NF-𝜅B [8]. To determine whether the anti-inflammatory
effects of TIE are mediated through the MAPK inactivation,
Western blots were performed to analyze the levels of p-
ERK, JNK, and p38 in RAW246.7 cells. LPS/IFN𝛾 stimulation
(30min) evocated significant increases in the levels of phos-
phorylated ERK, JNK, and p38 in RAW246.7 cells. Coincu-
bation of TIE markedly inhibited the extent of ERK and p38
phosphorylation; meanwhile the amounts of nonphospho-
rylated p38 and ERK1/2 were apparently unaffected by LPS
or LPS plus TIE treatment (Figure 5(e) and supplemen-
tary data in the Supplementary Material available online at
http://dx.doi.org/10.1155/2015/350564). These results suggest
that TIE blocks inflammatory responses by the combination
of blocking NF-𝜅B, ERK, and p38 activation and slightly
enhanced phosphorylation of JNK (p-JNK) (𝑃 > 0.05).These
results suggested that the anti-inflammatory activity of TIE
was mediated by inhibition of the LPS-induced phosphory-
lation of p38 and ERK1/2. We found that TIE attenuated the
activation of p38, rather than that of ERK by stimulation.
These results indicated that the inhibitory effects of TIE
on NO and PGE2 were mediated partly via the downstream
MAPKs pathway.
3.6. miR155 Repression Was Involved in TIE Anti-
Inflammatory Effects. MAPKs and NF-𝜅B, two downstream
pathways of TLR4 signalling, were shown to positively regu-
late the expression of miR155 [14]. As miR155 play important
roles in the innate immune response and inflammation, we
evaluated the effect of TIE on the expression of miR155 by
TaqMan MicroRNA assay. As shown in Figure 5(f), miR155
also dramatically increased after 24 h stimulation, and TIE
reduced LPS plus IFN𝛾-induced miR155 expression by
85.87%–90.77% from the dosage from 12.5 to 25 𝜇M.
This result showed that miR155 repression was involved
in TIE anti-inflammatory effects of NO, PGE2, and IL-6
production, as a complementary regulation at an epigenetics
level.
4. Discussion
Natural production has been used as medicine for treating
a wide variety of disorders including acute and chronic
inflammation. Garcinia esculenta Y. H. Li (Clusiaceae) is
a well-known herb in treating inflammation and tumor
for hundreds of years according to Chinese traditional
medicine though material basis and its mechanism of anti-
inflammation are still unclear.
With the help of the activity guiding extraction and sep-
aration, we caught some compounds isolated from Garcinia
esculentaY.H. Li (Clusiaceae) [13]. Among these compounds,
TIE had the strongest capability of inhibition of NO pro-
duction on stimulated macrophage RAW264.7 during the
screening procedure, which indicated the potential of its anti-
inflammatory effect in vitro.
However the mechanisms of anti-inflammatory effects of
TIE have not been delineated yet. Thus, our study aimed to
elucidate the mechanisms underlying the anti-inflammatory
effects of TIE.
It is well known that the overproduction of NO and
PGE2 by iNOS and COX-2 plays a critical role in the
regulation of the inflammatory process. Therefore, to study
the suppression of NO and PGE2 by iNOS and COX-2 is
very important in the development of anti-inflammatory
agents [19, 20]. Selective iNOS inhibitor showed the anti-
inflammatory and antitumor properties in animalmodels [21,
22]. Here, we demonstrated that TIE can dose-dependently
inhibit LPS plus INF-induced NO production in RAW264.7
macrophages, as well as suppression of PGE2 (Figure 2).
Consistent with these findings, TIE also suppressed induced
expression of iNOS and COX-2 at the mRNA and protein
levels in RAW264.7macrophages (Figure 3), which suggested
that TIE-induced reduction of NO and PGE2 may be due to
transcriptional suppression of iNOS and COX-2 genes.
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Figure 5: Effect of TIE on NF-𝜅B, MAPK activation, and miR155 expression in LPS/IFN𝛾-stimulated RAW264.7 cells. (a) RAW264.7 cells
were transiently cotransfected with a pNF-𝜅B reporter vector. Cells were incubated with TIE (3.125, 6.25, 12.5, and 25 𝜇M) and L-NIL (50 𝜇M)
for 1 h before stimulation with LPS and IFN𝛾 for 18 h. Luciferase activities were measured by Dual Luciferase Reporter reagents following
manufacturer’s instruction. Luciferase activity was normalized to transfection efficiency as monitored by Renilla luciferase expression. (b,
c) DNA-binding activity of p65 and p50 proteins in nuclear extracts was assessed using NF-𝜅Bp50/p65 EZ-TFA transcription factor assay.
Absorbance was measured at 450 nm in a microplate spectrophotometer. Results were normalized to absorbance/mg protein. (d) RAW264.7
cells (1 × 106 cells/dish) were treated with varying doses of TIE with IFN𝛾 (10U/mL) plus LPS (100 ng/mL) for 4 h. Total RNA was isolated
and subjected to qRT-PCR to determine the level of TBK1 mRNA. (e) RAW264.7 cells were plated at a density of 1 × 106 cells/well in 30mm
dish overnight. TIE was added to cells followed by 30min stimulation of IFN𝛾 (10U/mL) plus LPS (100 ng/mL). Whole cell lysates were
prepared and subjected to Western blotting. The ratios of immunointensity of p-ERK1/2, p-JNK, and p-p38 were calculated, respectively.
Total ERK1/2, JNK, and p38 (T-ERK1/2, T-JNK, and T-p38) were used as a control of the protein amount in the same samples. Data shown are
the representative of three independent experiments. (f) The cells were stimulated by IFN𝛾 (10U/mL) plus LPS (100 ng/mL) with or without
12.5 and 25 𝜇M concentrations of TIE for 24 h. Total RNA was isolated and the expression of miR155 was determined by qRT-PCR. RNU6B
was used here as an endogenous control. The data represent the mean ± SD of triplicate experiments. ##𝑃 < 0.01, #𝑃 < 0.05 versus control
group; ∗∗𝑃 < 0.01, ∗𝑃 < 0.05 versus model group.
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Induction of iNOS is often accompanied with upregu-
lation proinflammatory cytokines in macrophages [23]. IL-
6, IL-12, and TNF-𝛼 play a critical role in innate immune
responses and it is the principal mediator in response to LPS
stimulated tissue injury and shock [24]. Therefore, we also
investigated the effect of TIE on LPS plus IFN𝛾-inducible
proinflammatory cytokines expression and secretion. TIE can
also diminish the expression and secretion of IL-6 as well as
gene expression of IL-12 and TNF-𝛼 (Figure 4).
The expression of a number of immunity and inflamma-
tory related genes such as iNOS, COX-2, and IL-6 was mod-
ulated by activated NF-𝜅B [25]. Activation of NF-𝜅B involves
the phosphorylation and subsequent proteolytic degradation
of the inhibitory protein I𝜅B by specific I𝜅B kinases. The
free NF-𝜅B (a heterodimer of p50 and p65) then passes into
the nucleus, where it binds to NF-𝜅B site in the promoter
regions of genes for inflammatory proteins such as cytokines,
enzymes, and adhesion molecules [26]. Under inflammatory
conditions, inhibitory protein I𝜅B is promptly phosphory-
lated and degraded from p50 and p65 subunits binding site
of NF-𝜅B, and the activated NF-𝜅B subunits migrate to the
nucleus. To investigate the possible preventive capability of
TIE on NF-𝜅B activation, we studied NF-𝜅B activity, p50/p65
nuclear translocation, and TBK1 expression.
LPS/IFN𝛾 stimulation caused the increase of TBK1
expression, activation of NF-𝜅B and induced p50/p65 move-
ment to nucleus, and TIE repressed luciferase intensity of
NF-𝜅B promoter in a dose dependent manner (Figure 5(a)).
The present study also showed that TIE inhibited LPS/IFN𝛾-
induced NF-𝜅B activation through the suppression of TBK1
expression (Figure 5(d)) and on the nuclear translocation of
the P50/P65 subunit of NF-𝜅B in RAW264.7 macrophages
(Figures 5(b) and 5(c)). So TIE displayed the interference in
progress of NF-𝜅B active heterology dimmer heading to the
nucleus and the binding capability.
The MAPKs pathway is one of the most ancient and
evolutionarily conserved signaling pathways and plays essen-
tial regulatory roles in both innate and adaptive immune
response [23]. LPS/IFN𝛾 stimulation of cytokines production
in human monocytes is involved in several intracellular
signaling pathways that include threeMAPK pathways: ERK1
and ERK2, JNK and p38, and IKK-NF-𝜅Bpathway [27].Thus,
we investigated the effect of TIE on activation of ERK1/2, JNK,
and p38 in LPS/IFN𝛾-stimulated cells. Our results showed
that the phosphorylation of p38 and ERK in response to
LPS/IFN𝛾 was decreased with TIE treatment, whereas JNK
phosphorylation was not affected (Figure 5(e)).
MicroRNAs are short noncoding RNAs that are involved
in the epigenetic regulation of cellular processes. The
macrophage inflammatory response to LPS stimulation
involves the upregulation of miRNAs such as miR155 and
miR146 and the downregulation of miR125b. Recently,
miR155 has been characterized as a component of the primary
macrophage response to different types of inflammatory
mediators [28]. Given the powerful role of miR155 in inflam-
mation, it may be an ideal candidate target for anti-inflam-
matory drug development.
Although results above had been made to identify
important and classic genes and pathways involved in
the anti-inflammatory effect of TIE, knowledge of noncod-
ing genes such as miRNAs and their contributions is less
understood. Our results showed that LPS/IFN𝛾 stimulation
induced miR155 expression substantially, and TIE reduced
LPS plus IFN𝛾-induced miR155 expression (Figure 5(f)).
This study highlights a novel mechanism for TIE effects on
the inflammatory response via downregulation of miR155
expression.
miR155 is known to be induced downstream of TLR4 sig-
naling. Inhibition of theNF-𝜅Bpathway significantly reduced
miR155 expression in LPS treatedRAW264.7 cells;meanwhile
induction ofNF-𝜅Bactivity rapidly leads to increased levels of
mature miR155 transcripts. Current study demonstrated that
MiR155HG is a direct NF-𝜅B target gene in vivo since NF-𝜅B-
responsive site exists in the MiR155HG proximal promoter
and miR155 is the diced product of the MiR155HG gene
[29, 30].These evidences reflect the importance of the NF-𝜅B
pathway in the induction of miR155.
In addition, TIE reduced the nuclear translocation of
p65/p50 by inflammatory stimulation, whereas inhibition of
NF-𝜅B activation elicited a downregulation of miR155 in LPS
treated macrophages, which indicated the important role of
the NF-𝜅B pathway in TIE-regulated miR155 expression.
In conclusion, this is the first investigation of the anti-
inflammatory activity of TIE and its functional mechanism
in activated macrophages RAW264.7 cells. TIE was found
to inhibit the production of NO and PGE2 as well as
their upstream enzymes iNOS and COX-2 at protein level
as well as secretion and expression of cytokines through
LPS/IFN𝛾 induced NF-𝜅B/MAPK/miR155 signaling path-
ways (Figure 6), indicating that TIE has a potential anti-
inflammatory application.
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